Method and composition for treating ocular hypertension and glaucoma
AssigneesSanten Pharmaceutical Co., Ltd., AGC Inc.
InventorsTimo REUNAMAKI, Pertti PELLINEN, Olli OKSALA, Kari LEHMUSSAARI
Life of this patent
Estimating the term…
Abstract
The present invention relates to an ophthalmic aqueous composition containing PGF2α analogues for treating ocular hypertension and glaucoma, to a method for treating ocular hypertension and glaucoma by administering said composition to a subject in need of such treatment, and to a method for increasing aqueous solubility and stability of PGF2α analogues in an aqueous composition.
Claims7
A method for treating ocular hypertension and glaucoma to a subject in need thereof, by administrating an ophthalmic aqueous solution comprising 0.0015% w/v tafluprost as an active ingredient, 0.075% w/v polysorbate 80 and 0.05% w/v disodium edetate, wherein the ophthalmic aqueous solution is stable and bioavailable at room temperature without benzalkonium chloride.
Dependencies are inferred from the claim text.